Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages

J Biol Chem. 2017 Apr 28;292(17):6855-6868. doi: 10.1074/jbc.M117.775205. Epub 2017 Feb 16.

Abstract

Mycobacterium tuberculosis is known to modulate the host immune responses to facilitate its persistence inside the host cells. One of the key mechanisms includes repression of class-II transactivator (CIITA) and MHC-II expression in infected macrophages. However, the precise mechanism of CIITA and MHC-II down-regulation is not well studied. M. tuberculosis 6-kDa early secretory antigenic target (ESAT-6) is a known potent virulence and antigenic determinant. The M. tuberculosis genome encodes 23 such ESAT-6 family proteins. We herein report that M. tuberculosis and M. bovis bacillus Calmette-Guérin infection down-regulated the expression of CIITA/MHC-II by inducing hypermethylation in histone H3 lysine 9 (H3K9me2/3). Further, we showed that M. tuberculosis ESAT-6 family protein EsxL, encoded by Rv1198, is responsible for the down-regulation of CIITA/MHC-II by inducing H3K9me2/3. We further report that M. tuberculosis esxL induced the expression of nitric-oxide synthase, NO production, and p38 MAPK pathway, which in turn was responsible for the increased H3K9me2/3 in CIITA via up-regulation of euchromatic histone-lysine N-methyltransferase 2 (G9a). In contrast, inhibition of nitric-oxide synthase, p38 MAPK, and G9a abrogated H3K9me2/3, resulting in increased CIITA expression. A chromatin immunoprecipitation assay confirmed that hypermethylation at the promoter IV region of CIITA is mainly responsible for CIITA down-regulation and subsequent antigen presentation. We found that co-culture of macrophages infected with esxL-expressing M. smegmatis and mouse splenocytes led to down-regulation of IL-2, a key cytokine involved in T-cell proliferation. In summary, we demonstrate that M. tuberculosis EsxL inhibits antigen presentation by enhancing H3K9me2/3 at the CIITA promoter, thereby repressing its expression through NO and p38 MAPK activation.

Keywords: EsxL; Mycobacterium smegmatis; Mycobacterium tuberculosis; histone methylation; macrophage; major histocompatibility complex (MHC); nitric oxide; nitric oxide synthase; p38 MAPK.

Publication types

  • Research Support, Non-U.S. Gov't
  • Retracted Publication

MeSH terms

  • Animals
  • Antigen Presentation
  • Antigens, Bacterial / metabolism
  • Bacterial Proteins / physiology*
  • Cell Line, Tumor
  • Cell Proliferation
  • DNA Methylation*
  • Genome, Bacterial
  • Histones / metabolism
  • Humans
  • Interleukin-10 / metabolism
  • Interleukin-2 / metabolism
  • Interleukin-6 / metabolism
  • MAP Kinase Signaling System
  • Macrophages / metabolism*
  • Mice
  • Mutation
  • Mycobacterium bovis / metabolism*
  • Mycobacterium tuberculosis / metabolism*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Nuclear Proteins / genetics*
  • RAW 264.7 Cells
  • Signal Transduction
  • Spleen / cytology
  • T-Lymphocytes / cytology
  • Trans-Activators / genetics*
  • Tumor Necrosis Factor-alpha / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Antigens, Bacterial
  • Bacterial Proteins
  • Histones
  • Interleukin-2
  • Interleukin-6
  • MHC class II transactivator protein
  • Nuclear Proteins
  • Trans-Activators
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • p38 Mitogen-Activated Protein Kinases